PERTINAX PHARMA LIMITED
Company number 09557364 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£2,195,757
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2015-04-23
- Registered office
- 2nd Floor Abbey House, 32 Booth Street, Manchester, M2 4AB
- Postcode
- M2 4AB
- Capital
- 18 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-04-23
- Next due by
- 2026-05-07
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 7 resigned
Public contracts won 1
£35,259 total awarded value where published.
Contains public sector information licensed under the Open Government Licence v3.0 (Contracts Finder).
Contact details
- Website
- pertinaxpharma.com
Pertinax materials provide sustained release of chlorhexidine. Pertinax can be used as a component of materials and devices such as medical foams, films and fibres. When in contact with a moist environment, Pertinax releases chlorhexidine over an extended period.
Previous registered addresses 5
| Address | Changed on |
|---|---|
| FUTURE SPACE UWE NORTH GATE FILTON ROAD, STOKE GIFFORD, BRISTOL, BS34 8RB, ENGLAND | 2020-02-13 |
| FUTURE SPACE UWE NORTH GATE, FILTON ROAD, STOKE GIFFORD, BRISTOL, BS34 8QZ, GREAT BRITAIN | 2017-04-06 |
| FUTURE SPACE UWE NORTH GATE, FILTON ROAD, STOKE GIFFORD, BRISTOL, BS34 8QZ, ENGLAND | 2016-11-16 |
| RED, SENATE HOUSE TYNDALL AVENUE, BRISTOL, BS8 1TH, ENGLAND | 2016-10-11 |
| RED SENATE HOUSE, TYNDAL AVE,, BRISTOL, AL, BS8 1TH, UNITED KINGDOM | 2015-09-24 |
The class of 2015
39%
of the 363 companies in this sector incorporated in 2015 are still active today; 58% have since been dissolved.
A fact about the year, not a forecast for this company.